Medpace Aktie News

Medpace's revenue growth was strong last quarter. The company is building up a backlog as the clinical trial sector recovers.

Medpace Holdings, Inc. continues to deliver robust double-digit revenue growth, with Q3 2025 revenue up 23.7% year-over-year and strong net new business awards. MEDP's full-service CRO model, focused on small and mid-sized biotech clients, underpins its credibility and drives future revenue growth opportunities. Full-year 2025 revenue guidance is $2.48–$2.53 billion, with potential MEDP upside ...

Medpace Holdings, Inc. (NASDAQ:MEDP ) Q3 2025 Earnings Call October 23, 2025 9:00 AM EDT Company Participants Lauren Morris - Associate Director of Investors Relations August Troendle - Chairman & CEO Jesse Geiger - President Kevin Brady - CFO & Treasurer Conference Call Participants Charles Rhyee - TD Cowen, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Michael Che...

The company's new orders soared 49% in the third quarter from a year ago.

Wayfair delivered one of its strongest quarters in recent years. ThredUp remains our largest investment. Carvana estimates its U.S. market share is still only about 1.5%.

Medpace rocketed late Wednesday on "another strong Q," that included double-digit sales and profit growth and a guidance hike.

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Results Revenue for the three months ended September 30, 2025 increased 23.7% to $659.9 million, compared to $533.3 million for the comparable prior-year period. On a constant currency basis, revenue for the...

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2025 financial results after the market close on Wednesday, October 22, 2025. The Company will host a conference call the following morning, Thursday, October 23, 2025, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested par...